TY - JOUR
T1 - Long-term course of early onset developmental and epileptic encephalopathy associated with 2q24.3 microduplication
AU - Masuda, Takuya
AU - Osaka, Hitoshi
AU - Tsuchida, Naomi
AU - Miyatake, Satoko
AU - Nishimura, Kou
AU - Takenouchi, Toshiki
AU - Takahashi, Takao
AU - Matsumoto, Naomichi
AU - Yamagata, Takanori
N1 - Funding Information:
This work was supported by AMED under grant numbers JP20ek0109486, JP21ek0109549, JP21cm0106503, and JP21ek0109493 (N. Matsumoto); JSPS KAKENHI grant numbers JP20K17428 (N. Tsuchida) and JP20K07907 (S. Miyatake); The Ichiro Kanehara Foundation for the Promotion of Medical Science & Medical Care (S. Miyatake); and the Kawano Masanori Memorial Public Interest Incorporated Foundation for Promotion of Pediatrics (S. Miyatake).
Publisher Copyright:
© 2022 The Author(s)
PY - 2022/1
Y1 - 2022/1
N2 - Copy number variations (CNVs) have been related to developmental and epileptic encephalopathy (DEE). The 2q24.3 region includes a cluster of genes for voltage-gated sodium channels (SCN) and CNVs in this region cause DEE. However, the long-term course of DEE with a 2q24.3 duplication has not been described. A 20-year-old female developed epileptic encephalopathy in early infancy that was resistant to various antiseizure medications. Her seizures disappeared after starting vitamin B6 therapy. Therefore, her epilepsy was considered pyridoxine-dependent epilepsy. At 16 years old, whole exome sequencing revealed a 2q24.3 microduplication including SCN1A, SCN2A, SCN3A, SCN7A, and SCN9A. Quantitative PCR detected an increased copy number of 1.3 Mb on 2q24.3 involving these genes, but no gene mutation accounting for pyridoxine-dependent epilepsy. Considering that with this duplication she was reported to be seizure-free after infancy, she was able to be off antiseizure medications including vitamin B6. Our case involvingdrug-resistant epilepsy in early infancy had no recurrent seizures during long-term follow up. Detecting CNVs using whole exome sequencing data was useful to identify a 2q24.3 duplication unassociated with pyridoxine-dependent epilepsy, leading to cessation of unnecessary medications.
AB - Copy number variations (CNVs) have been related to developmental and epileptic encephalopathy (DEE). The 2q24.3 region includes a cluster of genes for voltage-gated sodium channels (SCN) and CNVs in this region cause DEE. However, the long-term course of DEE with a 2q24.3 duplication has not been described. A 20-year-old female developed epileptic encephalopathy in early infancy that was resistant to various antiseizure medications. Her seizures disappeared after starting vitamin B6 therapy. Therefore, her epilepsy was considered pyridoxine-dependent epilepsy. At 16 years old, whole exome sequencing revealed a 2q24.3 microduplication including SCN1A, SCN2A, SCN3A, SCN7A, and SCN9A. Quantitative PCR detected an increased copy number of 1.3 Mb on 2q24.3 involving these genes, but no gene mutation accounting for pyridoxine-dependent epilepsy. Considering that with this duplication she was reported to be seizure-free after infancy, she was able to be off antiseizure medications including vitamin B6. Our case involvingdrug-resistant epilepsy in early infancy had no recurrent seizures during long-term follow up. Detecting CNVs using whole exome sequencing data was useful to identify a 2q24.3 duplication unassociated with pyridoxine-dependent epilepsy, leading to cessation of unnecessary medications.
KW - 2q24.3 microduplication
KW - Copy number variations
KW - Developmental and epileptic encephalopathy
KW - Voltage-gated sodium channel
UR - http://www.scopus.com/inward/record.url?scp=85131964280&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85131964280&partnerID=8YFLogxK
U2 - 10.1016/j.ebr.2022.100547
DO - 10.1016/j.ebr.2022.100547
M3 - Article
AN - SCOPUS:85131964280
SN - 2213-3232
VL - 19
JO - Epilepsy and Behavior Reports
JF - Epilepsy and Behavior Reports
M1 - 100547
ER -